HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].

AbstractOBJECTIVE:
To investigate the role of pelvic exenteration in the treatment of advanced gynecological malignances.
METHODS:
Eighteen patients with cervical cancer in 8, vulvar cancer in 8, and vaginal cancer in 2, who underwent pelvic exenteration at the Cancer Hospital of Shanghai Medical University between 1970 and 1990 were retrospectively analyzed.
RESULT:
Median age was 52 years (range 27-65). One woman received surgery of total pelvic exenteration, 10 anterior and 7 posterior exenteration. The 3,5-year survival rates were 72%, 50%, respectively. Postoperative morbidity was 16%, and the surgical mortality was 0%. Bowel obstruction occurred in 2 of 18 cases, one of them was treated surgically.
CONCLUSIONS:
(1) Patients with advanced central type pelvic neoplasms can be successfully treated with exenteration; (2) The patients should be properly selected prior to and in operation, and the procedures must be performed specifically, particularly in exploration stage.
AuthorsZ Zhang, R Zang, J Chen
JournalZhonghua fu chan ke za zhi (Zhonghua Fu Chan Ke Za Zhi) Vol. 35 Issue 5 Pg. 288-90 (May 2000) ISSN: 0529-567X [Print] China
PMID11775910 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Female
  • Genital Neoplasms, Female (mortality, surgery)
  • Humans
  • Middle Aged
  • Pelvic Exenteration (adverse effects)
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: